Key facts
- Maison Epigenetic’s last known valuation is $8.5M (Apr 2025).
- It has raised $1.1M; the latest was Seed Round ($1.1M) in Apr 2025.
- Notable investors include Vessoa Private Equity.
- Status: Privately Held (backing).
Investors
1- ·The complete investor list — 1 names
- ·Watchlist + deal alerts for Maison Epigenetic
- ·The full record, as it builds
Funding rounds
No funding rounds for Maison Epigenetic are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Maison Epigenetic
Operator of a health and wellness center intended to help clients measure, understand, and act on their health and well-being. The company specializes in an in-depth holistic assessment, a personalized protocol of paramedical treatments, physical and mental activities, care, and nutrition, thereby helping clients regenerate and reach their full physiological, psychological, and energetic potential.
- Sector
- Healthcare
- HQ
- Paris, France
- Founded
- 2020
- Employees
- 7
- Website
- maisonepigenetic.com/
- Ownership
- Privately Held (backing)
Maison Epigenetic doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Maison Epigenetic shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Maison Epigenetic in its N-PORT filings yet. We sweep new filings monthly.